Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) was the target of a large decline in short interest in March. As of March 31st, there was short interest totalling 4,700 shares, a decline of 6.0% from the March 15th total of 5,000 shares. Based on an average daily volume of 7,800 shares, the days-to-cover ratio is currently 0.6 days.
Eupraxia Pharmaceuticals Price Performance
EPRXF stock opened at C$2.70 on Wednesday. Eupraxia Pharmaceuticals has a 12 month low of C$2.93 and a 12 month high of C$6.78. The firm has a 50 day simple moving average of C$4.07 and a 200 day simple moving average of C$4.18.
Eupraxia Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Eupraxia Pharmaceuticals
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
- What is a Secondary Public Offering? What Investors Need to Know
- Checking in with 5 Bitcoin Stocks Ahead of Bitcoin’s Halving
- What Makes a Stock a Good Dividend Stock?
- Commercial Banks Could Be Back in Play, Led by Bank of America
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.